Fig. 2From: Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreasReceiver operating characteristic curves for serum levels of CA19-9, CA125 and CEA. Receiver operating characteristic curves of CA19-9 (A), CA125 (B) and CEA (C) for predicting malignant IPMNs. AUC, area under curve; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; IPMN, intraductal papillary mucinous neoplasmBack to article page